» Articles » PMID: 33395425

Epidemiological, Socio-demographic and Clinical Features of the Early Phase of the COVID-19 Epidemic in Ecuador

Abstract

The SARS-CoV-2 virus has spread rapidly around the globe. Nevertheless, there is limited information describing the characteristics and outcomes of COVID-19 patients in Latin America. We conducted a cross-sectional analysis of 9,468 confirmed COVID-19 cases reported in Ecuador. We calculated overall incidence, mortality, case fatality rates, disability adjusted life years, attack and crude mortality rates, as well as relative risk and relative odds of death, adjusted for age, sex and presence of comorbidities. A total of 9,468 positive COVID-19 cases and 474 deaths were included in the analysis. Men accounted for 55.4% (n = 5, 247) of cases and women for 44.6% (n = 4, 221). We found the presence of comorbidities, being male and older than 65 years were important determinants of mortality. Coastal regions were most affected by COVID-19, with higher mortality rates than the highlands. Fatigue was reported in 53.2% of the patients, followed by headache (43%), dry cough (41.7%), ageusia (37.1%) and anosmia (36.1%). We present an analysis of the burden of COVID-19 in Ecuador. Our findings show that men are at higher risk of dying from COVID-19 than women, and risk increases with age and the presence of comorbidities. We also found that blue-collar workers and the unemployed are at greater risk of dying. These early observations offer clinical insights for the medical community to help improve patient care and for public health officials to strengthen Ecuador's response to the outbreak.

Citing Articles

Surviving COVID-19 and Battling Fibrosis: A Retrospective Cohort Study Across Three Pandemic Waves.

Lazar M, Barbu E, Chitu C, Buzoianu M, Petre A, Tiliscan C Diagnostics (Basel). 2025; 14(24.

PMID: 39767173 PMC: 11674708. DOI: 10.3390/diagnostics14242811.


Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors.

Gaviria A, Tamayo-Trujillo R, Paz-Cruz E, Cadena-Ullauri S, Guevara-Ramirez P, Ruiz-Pozo V Front Cell Infect Microbiol. 2024; 14:1373450.

PMID: 38975325 PMC: 11224293. DOI: 10.3389/fcimb.2024.1373450.


Parity of esteem: A global COVID-19 vaccination approach for people with mental illnesses, based on facts from 34 countries; recommendations and solutions.

Shoib S, Saeed F, Philip S, Chandradasa M, Das S, de Filippis R Ind Psychiatry J. 2024; 33(1):30-40.

PMID: 38853796 PMC: 11155657. DOI: 10.4103/ipj.ipj_54_22.


Maternal mortality and COVID-19: A nationwide ecological analysis from Ecuador.

Ortiz-Prado E, Izquierdo-Condoy J, Fernandez-Naranjo R, Vasconez-Gonzalez J, Izquierdo-Condoy N, Checa-Jaramillo D Womens Health (Lond). 2024; 20:17455057231219607.

PMID: 38553804 PMC: 10981214. DOI: 10.1177/17455057231219607.


A proposed analytical approach to estimate excess daily mortality rates in Ecuador.

Fernandez-Naranjo R, Vasconez-Gonzalez J, Izquierdo-Condoy J, Landazuri S, Castillo D, Ortiz-Prado E Front Public Health. 2024; 12:1250343.

PMID: 38525341 PMC: 10957652. DOI: 10.3389/fpubh.2024.1250343.


References
1.
Bernstein S, Rehkopf D, Tuljapurkar S, Horvitz C . Poverty dynamics, poverty thresholds and mortality: An age-stage Markovian model. PLoS One. 2018; 13(5):e0195734. PMC: 5955488. DOI: 10.1371/journal.pone.0195734. View

2.
Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S . Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020; 14(2):125-128. DOI: 10.3855/jidc.12600. View

3.
Salomon J, Haagsma J, Davis A, Maertens de Noordhout C, Polinder S, Havelaar A . Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015; 3(11):e712-23. DOI: 10.1016/S2214-109X(15)00069-8. View

4.
Mokdad A, Forouzanfar M, Daoud F, Mokdad A, El Bcheraoui C, Moradi-Lakeh M . Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016; 387(10036):2383-401. DOI: 10.1016/S0140-6736(16)00648-6. View

5.
Torres-Roman J, Kobiak I, Valcarcel B, Diaz-Velez C, La Vecchia C . The reproductive number R0 of COVID-19 in Peru: An opportunity for effective changes. Travel Med Infect Dis. 2020; 37:101689. PMC: 7194686. DOI: 10.1016/j.tmaid.2020.101689. View